Funded Project Details - FY2021
|Title:|| Determining and targeting reasons for low statin use to improve guideline-concordant statin therapy in high-risk patients|
Salim S. Virani
|Congressional District Code:
||Health Services R&D
|| July 2017 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Background: Optimal statin therapy is associated with a lower risk of cardiovascular events in patients with established cardiovascular disease (CVD). The VA External Peer Review Program (EPRP) also recommends moderate-high intensity statins in patients with CVD. We have shown that a large proportion of Veterans with CVD (41%) are on suboptimal statin therapy. Guideline concordant statin treatment over 5 years could potentially prevent 20,611 vascular events including 3,435 deaths in Veterans wi...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.